Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.860
+0.080 (4.49%)
At close: Sep 4, 2026, 4:00 PM EDT
1.910
+0.050 (2.69%)
After-hours: Sep 4, 2026, 7:59 PM EDT
Skye Bioscience Employees
Skye Bioscience had 2 employees as of June 30, 2026.
Employees
2
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$25,246,289
Market Cap
8.24M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 2 | - | - |
| Mar 31, 2026 | 2 | -14 | -87.50% |
| Dec 31, 2025 | 12 | -4 | -25.00% |
| Dec 31, 2024 | 16 | 5 | 45.45% |
| Dec 31, 2023 | 11 | 0 | - |
| Dec 31, 2022 | 11 | 2 | 22.22% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 38 |
| Bolt Biotherapeutics | 23 |
| Imunon | 20 |
| Soligenix | 14 |
| Ensysce Biosciences | 10 |
| CNS Pharmaceuticals | 8 |
| Traws Pharma | 7 |
| Alzamend Neuro | 6 |
SKYE News
- 14 days ago - Skye Bioscience Proxy statement: Proxy filing - Filings
- 16 days ago - Skye Bioscience Inc trading halted, news pending - TheFly
- 18 days ago - Skye Bioscience Proxy statement: Proxy filing - Filings
- 19 days ago - Skye Bioscience Proxy statement: Proxy filing - Filings
- 22 days ago - Skye Bioscience Inc trading halted, news pending - TheFly
- 22 days ago - Skye Bioscience to acquire Redx Pharma via scheme of arrangement - TheFly
- 22 days ago - Skye Bioscience Inc trading resumes - TheFly
- 23 days ago - Skye Bioscience Quarterly report: Q2 2026 - Filings